Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma.

Gustafson WC, Matthay KK.

Expert Rev Neurother. 2011 Oct;11(10):1411-23. doi: 10.1586/ern.11.103. Review.

PMID:
21955198
2.

Neuroblastoma: biology, prognosis, and treatment.

Park JR, Eggert A, Caron H.

Pediatr Clin North Am. 2008 Feb;55(1):97-120, x. doi: 10.1016/j.pcl.2007.10.014. Review.

PMID:
18242317
3.

Neuroblastoma: biology, prognosis, and treatment.

Park JR, Eggert A, Caron H.

Hematol Oncol Clin North Am. 2010 Feb;24(1):65-86. doi: 10.1016/j.hoc.2009.11.011. Review.

PMID:
20113896
4.

Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research.

Øra I, Eggert A.

Semin Cancer Biol. 2011 Oct;21(4):217-28. doi: 10.1016/j.semcancer.2011.07.002. Epub 2011 Jul 20. Review.

PMID:
21798350
5.

[Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].

Pérel Y, Valteau-Couanet D, Michon J, Lavrand F, Coze C, Bergeron C, Notz A, Plantaz D, Chastagner P, Bernard F, Thomas C, Rubie H.

Arch Pediatr. 2004 Jul;11(7):834-42. Review. French.

PMID:
15234382
6.

Neuroblastoma, retinoblastoma, and brain tumors in children.

Brodeur GM, Saylors RL 3rd.

Curr Opin Oncol. 1991 Jun;3(3):485-96. Review.

PMID:
1892917
7.

Risk-based management: current concepts of treating malignant solid tumors of childhood.

Grosfeld JL.

J Am Coll Surg. 1999 Oct;189(4):407-25. Review.

PMID:
10509467
8.

Neuroblastoma: biology and staging.

Mueller S, Matthay KK.

Curr Oncol Rep. 2009 Nov;11(6):431-8. Review.

PMID:
19840520
9.

Advances in the diagnosis and treatment of neuroblastoma.

Weinstein JL, Katzenstein HM, Cohn SL.

Oncologist. 2003;8(3):278-92. Review.

10.

Neuroblastoma: paradigm for precision medicine.

Irwin MS, Park JR.

Pediatr Clin North Am. 2015 Feb;62(1):225-56. doi: 10.1016/j.pcl.2014.09.015. Review.

PMID:
25435121
11.

Biology and treatment of neuroblastoma.

Castleberry RP.

Pediatr Clin North Am. 1997 Aug;44(4):919-37. Review.

PMID:
9286292
12.

Aiming at neuroblastoma and hitting other worthy targets.

Schor NF.

J Child Neurol. 2013 Jun;28(6):768-73. doi: 10.1177/0883073813483173. Epub 2013 Apr 10. Review.

PMID:
23576410
13.

Current aspects of biology, risk assessment, and treatment of neuroblastoma.

Haase GM, Perez C, Atkinson JB.

Semin Surg Oncol. 1999 Mar;16(2):91-104. Review.

PMID:
9988866
14.

Pharmacotherapy of neuroblastoma.

George RE, Diller L, Bernstein ML.

Expert Opin Pharmacother. 2010 Jun;11(9):1467-78. doi: 10.1517/14656566.2010.482100. Review.

PMID:
20408767
15.

At the frontier of progress for paediatric oncology: the neuroblastoma paradigm.

Moreno L, Marshall LV, Pearson AD.

Br Med Bull. 2013;108:173-88. doi: 10.1093/bmb/ldt033. Epub 2013 Nov 7. Review.

PMID:
24211816
16.

Neuroblastoma update.

Henry MC, Tashjian DB, Breuer CK.

Curr Opin Oncol. 2005 Jan;17(1):19-23. Review.

PMID:
15608507
17.

Neuroblastoma: biology and therapy.

Matthay KK.

Oncology (Williston Park). 1997 Dec;11(12):1857-66; discussion 1869-72, 1875. Review.

18.

Neuroblastoma imaging.

Ley S, Ley-Zaporozhan J, Günther P, Deubzer HE, Witt O, Schenk JP.

Rofo. 2011 Mar;183(3):217-25. doi: 10.1055/s-0029-1245903. Epub 2010 Dec 17. Review.

PMID:
21170823
19.

Neuroblastoma therapy: what is in the pipeline?

Verissimo CS, Molenaar JJ, Fitzsimons CP, Vreugdenhil E.

Endocr Relat Cancer. 2011 Nov 14;18(6):R213-31. doi: 10.1530/ERC-11-0251. Print 2011 Dec. Review.

20.

Individualized targeted therapy for glioblastoma: fact or fiction?

Weller M, Stupp R, Hegi M, Wick W.

Cancer J. 2012 Jan-Feb;18(1):40-4. doi: 10.1097/PPO.0b013e318243f6c9. Review.

PMID:
22290256

Supplemental Content

Support Center